TB Antibody One Step Test # R-6017
Tuberculosis (TB) remains an important socio-economical and medical problem throughout the world. In 1995, more people died of tuberculosis in the world than of any other infectious disease. According to the Centre for Disease Control, the incidence of TB is expected to increase from 7.5 million cases per year in 1995 to 11.9 million in 2005. The case fatality rate is estimated at 55% for untreated people and 15% for the treated patients.
The commonly used diagnostic tests for the tuberculosis such as sputum examination of acid fast bacilli, culture of sputum or other fluids, the tuberculin skin test and radiological investigations do not achieve the required diagnostic sensitivity.
Actually, the best assets for clinical and epidemiological work in the diagnosis of tuberculosis are serological tests such as haemagglutination, complement fixation, immunofluorescence, ELISA and radioimmunodiffusion techniques. But the highly qualified technicians and expensive material needed to perform tuberculosis tests using the above methods are a serious limitation in non developed countries.
The One Step TB Antibody One-step Test (Cat.No.R-6017) is a rapid qualitative screening test for the detection of human antibodies to Koch's bacillus in serum, plasma, or whole blood. The test is able to specifically detect antibodies from patient in active phase of the disease. Samples from vaccinated people will not react with Novamed's TB Antibody One-step Test.
FOR FURTHER INFORMATION EMAIL US OR CALL: +972-2-6781861